SCHEMBL29930775

SCHEMBL29930775

C[Si](C)(C)CCOCn1nc(-c2ccc([N+](=O)[O-])cc2)c2cc(Br)cnc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.35
RAB9A P51151 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
XDH P47989 1/20 0.35
DGAT1 O75907 3/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
NLRP3 Q96P20 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930812 0.91 PDE4A (0.39) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL1592834 0.86 MERTK (0.39) NPC1DGAT1ALDH1A1
SCHEMBL29930517 0.85 PTPN11 (0.47) MAPTRAB9AMEN1KMT2ANPC1
SCHEMBL29930809 0.85 DGAT1 (0.37) MAPTNPC1DGAT1SMN1; SMN2HTT
SCHEMBL29930779 0.84 AXL (0.41) MAPTRAB9AMEN1KMT2ADGAT1
SCHEMBL29930508 0.82 DGAT1 (0.36) MAPTDGAT1
SCHEMBL29930721 0.82 MERTK (0.42) MAPTRAB9ANPC1DGAT1HPGD
SCHEMBL29930707 0.81 DYRK1A (0.45) MEN1KMT2A
SCHEMBL29930401 0.81 DYRK1B (0.40) DGAT1
SCHEMBL29930917 0.80 DYRK1B (0.38) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed